5-((3-((4S,6S)-2-(bis(4-methoxyphenyl)(phenyl)methylamino)-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)ethynyl)nicotinonitrile | 1620829-04-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: 5-((3-((4S,6S)-2-(bis(4-methoxyphenyl)(phenyl)methylamino)-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)ethynyl)nicotinonitrile
• 英文别名: 5-[2-[3-[(4S,6S)-2-[[bis(4-methoxyphenyl)-phenylmethyl]amino]-4-methyl-6-(trifluoromethyl)-5,6-dihydro-1,3-oxazin-4-yl]-4-fluorophenyl]ethynyl]pyridine-3-carbonitrile
• CAS: 1620829-04-0
• 化学式: C₄₁H₃₂F₄N₄O₃
• 分子量: 704.724
• InChiKey: OTLTUWJDDMLNBT-QARUCVQPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.4
• 重原子数：
  52
• 可旋转键数：
  10
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  88.8
• 氢给体数：
  1
• 氢受体数：
  10

反应信息

• 作为产物：
  描述：

  (4S,6S)-N-(bis(4-methoxyphenyl)(phenyl)methyl)-4-(2-fluoro-5-iodophenyl)-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazin-2-amine 、 5-((trimethylsilyl)ethynyl)nicotinonitrile 以the product 5-((3-((4S,6S)-2-(bis(4-methoxyphenyl)(phenyl)methylamino)-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)ethynyl)nicotinonitrile (XVI-56) was obtained after chromatography on silica gel (eluent: heptane-EtOAc; gradient: 0-30% EtOAc) as a light yellow foam (73% yield)的产率得到5-((3-((4S,6S)-2-(bis(4-methoxyphenyl)(phenyl)methylamino)-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)ethynyl)nicotinonitrile
  参考文献：
  名称：

  FLUORO-[1,3]OXAZINES AS BACE1 INHIBITORS

  摘要：

  本发明提供一种具有BACE1抑制活性的I型化合物，其制造方法，包含它们的制药组合物以及它们作为治疗活性物质的用途。本发明的活性化合物在治疗和/或预防阿尔茨海默病等疾病方面非常有用。

  公开号：

  US20150376172A1

文献信息

• [EN] FLUORO-[1,3]OXAZINES AS BACE1 INHIBITORS<br/>[FR] FLUORO- [1,3] OXAZINES SERVANT D'INHIBITEURS DE LA BACE1
  申请人：HOFFMANN LA ROCHE

  公开号：WO2014114532A1

  公开（公告）日：2014-07-31

  The present invention provides a compound of formula I having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

  本发明提供了具有BACE1抑制活性的化合物I的化合物，其制备方法，含有它们的药物组合物以及它们作为治疗活性物质的用途。本发明的活性化合物在治疗和/或预防治疗例如阿尔茨海默病等疾病方面是有用的。
• FLUORO-[1,3]OXAZINES AS BACE1 INHIBITORS
  申请人：WOLTERING Thomas

  公开号：US20150376172A1

  公开（公告）日：2015-12-31

  The present invention provides a compound of formula I having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

  本发明提供一种具有BACE1抑制活性的I型化合物，其制造方法，包含它们的制药组合物以及它们作为治疗活性物质的用途。本发明的活性化合物在治疗和/或预防阿尔茨海默病等疾病方面非常有用。